4[4]Torres JL,Ridker PM Clinical use of high-sensitivity C-reactive protein or the prediction of adverse cardiovascular events[J].Curr Opin Cardiol,2003,18(6):471.
5[5]Lagrand WK,Visser CA,Hermens WT,et al.C-reactive protein as a cardiovascular risk factor more than an epiphenomenon[J].Circulation,1999,100:96-102.
6[6]Yu H,Rifai NA.Hish sensitivity C-reactive protein andatherosclerosis:from theory to therapy[J].Clin Biochem,2000,33:601-610.
7[7]Sattar N,Gaww A,Scherbakova O,et al.Metabolic syndromewith and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study[J].Circulation,108:414-441.